Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VREX 
Varex Imaging Corp (VREX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: VREX (1-star) is a SELL. SELL since 4 days. Simulated Profits (0.28%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $17.8
1 Year Target Price $17.8
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 12.45% | Avg. Invested days 47 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 480.81M USD | Price to earnings Ratio - | 1Y Target Price 17.8 |
Price to earnings Ratio - | 1Y Target Price 17.8 | ||
Volume (30-day avg) 5 | Beta 0.96 | 52 Weeks Range 6.76 - 16.93 | Updated Date 10/17/2025 |
52 Weeks Range 6.76 - 16.93 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.23 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -16.13% | Operating Margin (TTM) -39.75% |
Management Effectiveness
Return on Assets (TTM) -1.96% | Return on Equity (TTM) -24.79% |
Valuation
Trailing PE - | Forward PE 24.69 | Enterprise Value 730636000 | Price to Sales(TTM) 0.59 |
Enterprise Value 730636000 | Price to Sales(TTM) 0.59 | ||
Enterprise Value to Revenue 0.89 | Enterprise Value to EBITDA 9.87 | Shares Outstanding 41520742 | Shares Floating 40967555 |
Shares Outstanding 41520742 | Shares Floating 40967555 | ||
Percent Insiders 1.65 | Percent Institutions 95.43 |
Upturn AI SWOT
Varex Imaging Corp
Company Overview
History and Background
Varex Imaging Corp. was formed in 2017 as a spin-off from Varian Medical Systems (now part of Siemens Healthineers). It focuses on developing and manufacturing X-ray imaging components.
Core Business Areas
- Medical Imaging: Provides X-ray tubes, digital detectors, and image processing solutions for medical diagnostic imaging applications.
- Industrial Imaging: Offers X-ray imaging components and software for non-destructive testing, security screening, and industrial inspection.
- Security: Provide advanced technology and imaging solutions in security applications. Solutions range from mail screening, cargo screening, and personal baggage at airports.
Leadership and Structure
Clarence Verhoef is the CEO. The company has a typical corporate structure with executive leadership across finance, operations, sales, and technology.
Top Products and Market Share
Key Offerings
- X-Ray Tubes: Broad portfolio of X-ray tubes used in medical, industrial, and security applications. Market share is estimated at 35%. Competitors include Dunlee, Comet, and Toshiba Electron Tubes.
- Digital Detectors: Flat panel detectors for radiography, fluoroscopy, and mammography. Market share is estimated at 20%. Competitors include Canon, Trixell, and Thales.
- Software and Workstations: Image processing and analysis software integrated with Varex imaging systems. Revenue from this area is approximately 15% of overall revenue. Competitors include Materialise and Mimics.
Market Dynamics
Industry Overview
The X-ray imaging market is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in imaging technology. Government regulations and healthcare spending also play a significant role.
Positioning
Varex Imaging Corp. is a leading independent supplier of X-ray imaging components. Its competitive advantages include a broad product portfolio, strong customer relationships, and technical expertise.
Total Addressable Market (TAM)
The global X-ray imaging market is expected to reach $40 billion by 2028. Varex is well-positioned to capture a share of this TAM through its diverse product offerings and established market presence.
Upturn SWOT Analysis
Strengths
- Strong market position
- Diverse product portfolio
- Established customer relationships
- Technical expertise
- Global presence
Weaknesses
- Reliance on a few key customers
- Exposure to cyclical industries
- Competition from larger players
- Supply chain vulnerabilities
- Debt Levels
Opportunities
- Growing demand for digital imaging
- Expanding applications in industrial and security markets
- Strategic acquisitions
- Development of new technologies
- Increased government investment in healthcare
Threats
- Technological obsolescence
- Intense price competition
- Economic downturns
- Changing regulatory landscape
- Disruptive new technologies
Competitors and Market Share
Key Competitors
- SI
- CAJ
- TDSCF
Competitive Landscape
Varex Imaging Corp. faces competition from larger, diversified companies as well as smaller, specialized players. Its competitive advantage lies in its broad product portfolio and technical expertise.
Major Acquisitions
Direct Conversion AB
- Year: 2018
- Acquisition Price (USD millions): 94
- Strategic Rationale: Expanded Varex Imaging's portfolio of digital detectors and strengthened its position in the medical imaging market.
Growth Trajectory and Initiatives
Historical Growth: Varex Imaging Corp. has experienced moderate revenue growth over the past few years, driven by demand for its products in medical and industrial markets.
Future Projections: Analysts project revenue growth of 4-6% per year over the next five years, with continued improvement in profit margins.
Recent Initiatives: Recent initiatives include expanding its product portfolio, investing in research and development, and making strategic acquisitions.
Summary
Varex Imaging Corp. holds a strong market position with a diverse portfolio, yet faces challenges like reliance on key customers and cyclical industry exposure. Growth is driven by digital imaging demand and strategic initiatives, but threats include technological obsolescence and competition. The company's financial performance shows moderate growth and improving profitability. Investors need to balance Varex's market strengths with industry risks and specific company weaknesses. Management needs to continue to diversify customer base and maintain innovation.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, Analyst reports, Market research reports
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share estimates are approximate and may vary based on different sources.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Varex Imaging Corp
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2017-01-20 | President, CEO & Director Mr. Sunny S. Sanyal | ||
Sector Healthcare | Industry Medical Devices | Full time employees 2300 | Website https://www.vareximaging.com |
Full time employees 2300 | Website https://www.vareximaging.com | ||
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.